» Articles » PMID: 37194304

Characteristics of Clinical-pharmacological Recommendations in Psychiatry in Germany

Overview
Publisher Sage Publications
Specialty Psychiatry
Date 2023 May 17
PMID 37194304
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Psychiatric patients in general, and elderly psychiatric patients in particular, are at risk of adverse drug reactions due to comorbidities and inappropriate polypharmacy. Interdisciplinary and clinical-pharmacologist-led medication reviews may contribute to medication safety in the field of psychiatry. In this study, we reported the frequency and characteristics of clinical-pharmacological recommendations in psychiatry, with a particular focus on geriatric psychiatry.

Method: A clinical pharmacologist, in collaboration with the attending psychiatrists and a consulting neurologist, conducted interdisciplinary medication reviews in a general psychiatric ward with a geropsychiatric focus at a university hospital over a 25-week period. All clinical and pharmacological recommendations were recorded and evaluated.

Results: A total of 316 recommendations were made during 374 medication reviews. Indications/contraindications of drugs were the most frequently discussed topics (59/316; 18.7 %), followed by dose reductions (37/316; 11.7 %), and temporary or permanent discontinuation of medications (36/316; 11.4 %). The most frequent recommendations for dose reduction benzodiazepines (9/37; 24.3 %). An unclear or absent indication was the most common reason for recommending temporary or permanent discontinuation of the medication (6/36; 16.7 %).

Conclusion: Interdisciplinary clinical pharmacologist-led medication reviews represented a valuable contribution to medication management in psychiatric patients, particularly the elderly ones.

Citing Articles

Impact of psychotropic pro re nata prescription-monitoring programme on prescriptions for inpatients with psychiatric disorders: a retrospective observational study.

Saito Y, Sumida K, Muraoka H, Oishi S, Suzuki R, Nishikawa T BMC Psychiatry. 2025; 25(1):46.

PMID: 39825279 PMC: 11742780. DOI: 10.1186/s12888-025-06508-w.


Prevalence and solving strategies of drug-related problems in adult psychiatric inpatients - a systematic review.

Wien K, Reissner P, Hefner G, Thern J, Borgwardt S Front Psychiatry. 2024; 15:1460098.

PMID: 39698211 PMC: 11652846. DOI: 10.3389/fpsyt.2024.1460098.

References
1.
. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015; 63(11):2227-46. DOI: 10.1111/jgs.13702. View

2.
Ates Bulut E, Isik A . Abuse/Misuse of Prescription Medications in Older Adults. Clin Geriatr Med. 2021; 38(1):85-97. DOI: 10.1016/j.cger.2021.07.004. View

3.
Javelot H, Faria C, Vandenberghe F, Dizet S, Langree B, Le Maout M . Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology. Pharmacy (Basel). 2021; 9(3). PMC: 8396352. DOI: 10.3390/pharmacy9030146. View

4.
Andreotti F, Rocca B, Husted S, Ajjan R, Berg J, Cattaneo M . Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J. 2015; 36(46):3238-49. DOI: 10.1093/eurheartj/ehv304. View

5.
Finnerup N, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin R . Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015; 14(2):162-73. PMC: 4493167. DOI: 10.1016/S1474-4422(14)70251-0. View